Notably, CCN5 enhances MET of pancreatic cancer cells [31] and loss of CCN5 promotes EMT and acquisition of stem cell-like phenotypes in estrogen-dependent MCF7 breast cancer cells [32]. The gene discussed is CCN5; the disease is breast carcinoma.